Roche Diagnostics Corporation
9115 Hague Road
About Roche Diagnostics Corporation
Founded in 1896, Roche is a global pioneer in pharmaceuticals and diagnostics and is the world’s largest biotech company, focused on advancing science to improve people’s lives. Roche is also the world leader in in vitro diagnostics and tissue-based cancer diagnostics. The Diagnostics division develops and produces medical tests that provide information to help healthcare professionals find the right treatment for patients and deliver the best patient care to improve, prolong and save lives.
We offer a wide range of research and in vitro (outside the body) diagnostic tools that help in the early detection, prevention, diagnosis and treatment of diseases like congestive heart failure, HIV, hepatitis and diabetes, as well as medical conditions like fertility and blood coagulation. These products and services are used by researchers, physicians, patients, healthcare facilities and laboratories around the world.
Roche Diagnostics has its North American headquarters in Indianapolis. The Roche campus, located at 96th Street and Hague Road, spans about 155 acres and is home to U.S. research and development, laboratory, manufacturing, distribution, IT and administrative operations. The campus supports six diagnostics business areas: Diabetes Care, Centralized Diagnostics, Sequencing and Life Science, Molecular Diagnostics, Point of Care Diagnostics and Tissue Diagnostics. About 4,000 employees report into Indianapolis, with about 2,900 working onsite.
Tweets by Roche
171 articles about Roche Diagnostics Corporation
With new Alzheimer’s drugs receiving—and expected to receive—FDA approval, the market for diagnostic biomarker tests is set to expand.
Development in Alzheimer's disease diagnosis in Canada: New tests help patients and caregivers make timely decisions
Roche Diagnostics, a division of Hoffmann-La Roche Limited, is proud to announce Health Canada approval for its Cerebrospinal Fluid (CSF) assays* to measure three biomarkers that are hallmarks of Alzheimer's pathology, beta-amyloid and tau proteins, in adults aged 55 and older being evaluated for the disease.
Alzheimer Society of Ontario Welcomes Health Canada Approval of New Test for Alzheimer’s Disease Detection
The Alzheimer Society of Ontario is encouraged by today’s Health Canada approval of three biomarker tests developed by Roche Diagnostics to detect indicators of Alzheimer’s disease pathology.
Jana Care to Enter Collaboration with Roche to Develop and Distribute Blood Testing Platform to Improve Remote Care for Patients With Chronic Kidney and Heart Disease
Jana Care, Inc. an early stage at-home In Vitro Diagnostics company, and Roche Diagnostics, a global leader in medicines and diagnostics, announced a collaboration agreement for its digitally connected, blood testing platform to enable patients to self-administer critical blood tests at-home and clinicians to review the test results remotely.
Glytec and Roche Announce Strategic Partnership to Bring Digital Health Innovation in Glycemic Decision Support to the Hospital Bedside
Glytec, the only provider of cloud-based insulin management software across the continuum of care, announced a strategic partnership with Roche Diagnostics USA, a division of the world’s largest biotech company and a global pioneer in pharmaceuticals and diagnostics.
Leading Diagnostics Companies Join Forces to Establish the Access to Comprehensive Genomic Profiling Coalition (ACGP)
Consortium aims to make comprehensive genomic profiling accessible to advanced cancer patients in the U.S. to inform medical management and improve patient outcomes.
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for May 22, 2020.
Inotrem S.A. announced that it has entered a worldwide licensing agreement with Roche Diagnostics for the commercialization of a mechanism-based companion diagnostic test using a soluble plasma protein.
Great Place to Work is an organization whose goal it is to assure that all people in the U.S. have a great place to work by 2030. One category for certified companies is Biotechnology & Pharmaceuticals, which listed 36 companies. BioSpace organized these 36 companies into its BioSpace Hotbed Regi...
Horizon Discovery Enters Into Agreement With Roche Diagnostics to Support the Development of Immunohistochemistry Assays for Oncology
Under the terms of the agreement, Horizon will develop and provide Reference Standard material expressing NTRK fusion biomarkers.
It is Roche Diagnostics' first collaboration agreement with a startup biotech company.
Roche Diagnostics Corporation: New Survey Suggests That 9 Out Of 10 Patients On Warfarin Would Find Self-Monitoring An Easy And Quick Way To Monitor Their Health
Histalim Strengthens Its Positioning In Multiplex IHC And Companion Diagnostic By Integrating Two New Roche Diagnostics Corporation Platforms
Good Start Genetics Announces Marketing Agreement With Roche Diagnostics Corporation For Carrier Screening In The United States
Roche Diagnostics Corporation Release: CoaguChek PT/ INR Devices For Use At The Point Of Care And For Patient Self-Testing Remain A Safe And Effective Option For Patients On Anticoagulation Therapy
Roche Diagnostics Corporation Release: Updated Cervical Cancer Screening Guidelines From Leading Ob-Gyn Society Support Expanded Use Of Cobas HPV Test For Primary Screening
Eli Lilly And Roche Diagnostics Corporation To Collaborate On Alzheimer's Disease Adjunct Diagnostic Tool
Roche Diagnostics Corporation Named To 2015 Working Mother 100 Best Companies Awarded Recognition For Progressive Workplace Programs
Roche Diagnostics Corporation Recognized By Healthcare Businesswomen's Association With ACE Award For Its Women's Leadership Initiative Business Resource Group